Case report: Interferon induced coma in Sheehan's syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 7, 1997, Pages 551-553

  Mabe, Katsuhiro ^a   Shinzawa, Haruhide ^a   Yamatani, Keiichi ^a   Takeda, Tadashi ^a   Ishibashi, Masamichi ^a   Yamada, Nobuo ^a   Misawa, Hiroyuki ^a   Wakabayashi, Hiroto ^a   Togashi, Hitoshi ^a   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Coma; Interferon therapy; Sheehan's syndrome

Indexed keywords

ALPHA INTERFERON; HYDROCORTISONE; THYROXINE;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; CHILDBIRTH; COMA; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOCHLOREMIA; HYPONATREMIA; HYPOPITUITARISM; PRIORITY JOURNAL;

EID: 8544275275     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00483.x     Document Type: Article

References (10)

1. Davis GL. Interferon treatment of chronic hepatitis C. Am. J. Med. 1994; 96 (1A): S41-6.
2. Iino S, Hino K, Yasuda K. Current state of interferon therapy for chronic hepatitis C. Intervirology 1994; 37: 87-100.
3. Hoofnagle JH, Di Bisceglie AM, Shindo M. Antiviral therapy of hepatitis C - present and future. J. Hepatol. 1993; 17: S130-6.
4. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992; 102: 2155-60.
5. Sakane N, Yoshida T, Yoshida K, Umekawa T, Kondo M, Shimatsu A. Reversible hypopituitarism after interferon alfa therapy. Lancet 1995; 345: 1305.
6. Fabris P, Betterle C, Floreani A et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 1992; 340: 548.
7. Merimsky O, Chaitchik S. Neurotoxicity of interferon-α. Anticancer Drugs 1992; 3: 567-70.
8. Barbarino A, Colasanti S, Corsello SM et al. Dexamethasone inhibition of interferon-α2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome. J. Clin. Endocrinol. Metab. 1995; 80: 1329-32.
9. Müller H, Hammes E, Hiemke C, Hess G. Interferon-alpha-2-induced stimulation of ACTH and cortisol secretion in man. Neroendocrinology 1991; 54: 499-503.
10. Wiedermann CJ, Vogel W, Tilg H et al. Suppression of thyroid function by interferon-alpha2 in man. Naunyn Schmiedeberg's Arch. Pharmacol. 1991; 343: 665-8.